These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2934362)

  • 1. Ciprofloxacin treatment of systemic salmonella infection in sensitive and resistance mice.
    Easmon CS; Blowers A
    J Antimicrob Chemother; 1985 Nov; 16(5):615-9. PubMed ID: 2934362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice.
    Fu KP; Hilliard J; Isaacson D; Tobia AJ; Rosenthale ME; McGuire JL
    J Antimicrob Chemother; 1990 Feb; 25(2):263-8. PubMed ID: 2184159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of resistance to Salmonella typhimurium infection in high and low antibody responder mice.
    Plant JE; Glynn AA
    Clin Exp Immunol; 1982 Nov; 50(2):283-90. PubMed ID: 6817955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of multiple resistance in Salmonella enteritidis during treatment with ciprofloxacin.
    Pers C; Søgaard P; Pallesen L
    Scand J Infect Dis; 1996; 28(5):529-31. PubMed ID: 8953688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice.
    Brunner H; Zeiler HJ
    Antimicrob Agents Chemother; 1988 Jan; 32(1):57-62. PubMed ID: 2964809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial effects of niridazole. I. Effect on infection of mice with Salmonella typhimurium.
    Hof H; Müller KM; Heine WD
    Chemotherapy; 1982; 28(2):143-52. PubMed ID: 7042230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural resistance to Salmonella typhimurium in different inbred mouse strains.
    Hormaeche CE
    Immunology; 1979 Jun; 37(2):311-8. PubMed ID: 381178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiply resistant Salmonella typhimurium septicaemia in an immunocompromised patient successfully treated with ciprofloxacin.
    Patton WN; Smith GM; Leyland MJ; Geddes AM
    J Antimicrob Chemother; 1985 Nov; 16(5):667-9. PubMed ID: 2934363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rufloxacin in Salmonella typhimurium infection in mice.
    Bonina L; Carbone M; Mastroeni P; Costa GB; Mastroeni P
    J Chemother; 1992 Dec; 4(6):353-7. PubMed ID: 1337552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptdin-2: a novel therapeutic agent for experimental Salmonella Typhimurium infection.
    Preet S; Verma I; Rishi P
    J Antimicrob Chemother; 2010 May; 65(5):991-4. PubMed ID: 20228082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with ciprofloxacin of Salmonella typhimurium infection in an immunocompromised host.
    Esposito S; Gaeta GB; Galante D; Barba D
    Infection; 1985; 13(6):288. PubMed ID: 2934339
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of host responses induced by Salmonella typhimurium infection in genetically resistant and susceptible mice.
    Takahashi M; Ushijima T; Seto A
    J Med Microbiol; 1990 Mar; 31(3):191-4. PubMed ID: 2179555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation.
    Webb MS; Boman NL; Wiseman DJ; Saxon D; Sutton K; Wong KF; Logan P; Hope MJ
    Antimicrob Agents Chemother; 1998 Jan; 42(1):45-52. PubMed ID: 9449259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment of mice with sera containing gamma interferon on the course of infection with Salmonella typhimurium strain LT-2.
    Izadkhah Z; Mandel AD; Sonnenfeld G
    J Interferon Res; 1980; 1(1):137-45. PubMed ID: 6180036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the therapeutic effect of propolis along with standard antibacterial drug in Salmonella enterica serovar Typhimurium infected BALB/c mice.
    Kalia P; Kumar NR; Harjai K
    BMC Complement Altern Med; 2016 Nov; 16(1):485. PubMed ID: 27887651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice.
    Butler T; Girard AE
    J Antimicrob Chemother; 1993 Feb; 31(2):313-9. PubMed ID: 8385094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of resistance to infection with Salmonella typhimurium in mice.
    Plant J; Glynn AA
    J Infect Dis; 1976 Jan; 133(1):72-8. PubMed ID: 1107437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the development of chloramphenicol resistance in Salmonella typhimurium.
    Wray C; Sojka WJ; Paterson AB
    Res Vet Sci; 1975 Jan; 18(1):94-9. PubMed ID: 1090986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of mouse genotype and bacterial virulence in the generation of interferon-gamma-producing cells during the early phase of Salmonella typhimurium infection.
    Benbernou N; Nauciel C
    Immunology; 1994 Oct; 83(2):245-9. PubMed ID: 7835942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic salmonella carriers with ciprofloxacin.
    Diridl G; Pichler H; Wolf D
    Eur J Clin Microbiol; 1986 Apr; 5(2):260-1. PubMed ID: 2941298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.